$NXTS Nexentis Technologies ripping higher 🚀 Up 30% 🔹 Market reacting to a fresh R&D milestone from wholly owned subsidiary MitoCareX Bio 🧬 🔹 Company says i

$NXTS Nexentis Technologies ripping higher 🚀 Up 30% 🔹 Market reacting to a fresh R&D milestone from wholly owned subsidiary MitoCareX Bio 🧬 🔹 Company says it generated a substantially improved hit molecule as it moves toward pre-clinical development 🔥 🔹 Focused on mitochondrial drug discovery …